Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Meridian Bioscience Inc

+ Add to Watchlist

VIVO:US

19.1300 USD 0.3300 1.76%

As of 20:10:00 ET on 04/24/2015.

Snapshot for Meridian Bioscience Inc (VIVO)

Open: 18.8700 Day's Range: 18.8500 - 19.5300 Volume: 378,287
Previous Close: 18.8000 52wk Range: 15.5600 - 21.3300 1-Yr Rtn: +1.17%

Stock Chart for VIVO

No chart data available.
  • VIVO:US 19.1300
  • 1D
  • 1M
  • 1Y
18.8000
Interactive VIVO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VIVO

Current P/E Ratio (ttm) 22.5070
Estimated P/E(09/2015) 22.2442
Relative P/E vs. SPX 1.2042
Earnings Per Share (USD) (ttm) 0.8500
Est. EPS (USD) (09/2015) 0.8600
Est. PEG Ratio 1.3903
Market Cap (M USD) 797.83
Shares Outstanding (M) 41.71
30 Day Average Volume 269,784
Price/Book (mrq) 4.9597
Price/Sale (ttm) 4.1111
Dividend Indicated Gross Yield 4.18%
Cash Dividend (USD) 0.2000
Dividend Ex-Date 04/30/2015
5 Year Dividend Growth 2.71%
Next Earnings Announcement 07/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VIVO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VIVO

Meridian Bioscience, Inc. manufactures, markets, and distributes diagnostic test kits, purified reagents, and related products. The Company also offers bio- pharmaceutical enabling technologies. Meridian specializes in gastrointestinal and upper respiratory infections, serology, parasitology, and fungal disease diagnosis, as well as rare reagents and specialty biologicals.

John A KraeutlerChief Executive OfficerMelissa A LuekeExec VP/CFO/Secretary
Richard L EberlyExec VP/Chief Commercial OfcrMichael C ShaughnessyExec VP/Pres:Meridian Diagnostics
More Company Profile & Key Executives for VIVO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil